Patents by Inventor Rhonda R. Voskuhl

Rhonda R. Voskuhl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION
    Publication number: 20170232003
    Abstract: Provided are methods for reducing the progression of cognitive decline in a post-menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.
    Type: Application
    Filed: September 29, 2015
    Publication date: August 17, 2017
    Inventor: Rhonda R. Voskuhl
  • ESTROGEN COMBINATION FOR TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20170049785
    Abstract: Provided are methods for treating multiple sclerosis using a continuous regimen of estrogen in combination with periodic administration of a progestogen.
    Type: Application
    Filed: April 27, 2015
    Publication date: February 23, 2017
    Inventor: Rhonda R. Voskuhl
  • PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY
    Publication number: 20170042910
    Abstract: This invention relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.
    Type: Application
    Filed: April 27, 2015
    Publication date: February 16, 2017
    Applicant: The Regents of the University of California
    Inventor: Rhonda R. Voskuhl
  • Estriol therapy for multiple sclerosis and other autoimmune diseases
    Patent number: 9168262
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including: multiple sclerosis (MS), rheumatoid arthritis (RA), autoimmune thyroiditis and uveitis. Most preferably the invention is used to treat a patient with a therapeutically effective amount of estriol of 8 milligrams once daily via oral administration to treat the symptoms or prevent the onset of multiple sclerosis.
    Type: Grant
    Filed: February 11, 2013
    Date of Patent: October 27, 2015
    Assignee: The Regents of the University of California
    Inventor: Rhonda R. Voskuhl
  • PREGNANCY HORMONE COMBINATION FOR TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20150182539
    Abstract: The present invention relates to pregnancy hormone combinations and methods of treatment for autoimmune diseases having at least two hormonal components, a pregnancy hormone (such as estriol), and a gestagen (such as levonorgestrel or norethindrone) thereby providing for the continuous, uninterrupted administration of pregnancy hormones for the treatment for autoimmune disorders, such as multiple sclerosis.
    Type: Application
    Filed: October 27, 2014
    Publication date: July 2, 2015
    Inventor: Rhonda R. Voskuhl
  • ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASES AND DISORDERS
    Publication number: 20150051178
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, including post-partum auto immune diseases. Most preferably the invention uses estrogens, estranges, estriol or estrogen receptor active agents to prevent or ameliorate clinical symptoms of these Th1-mediated (cell-mediated) autoimmune diseases known to either have an initial onset following the birth of a child or which are exacerbated in patients in the post-partum period.
    Type: Application
    Filed: July 16, 2014
    Publication date: February 19, 2015
    Inventor: Rhonda R. Voskuhl
  • Pregnancy hormone combination for treatment of autoimmune diseases
    Patent number: 8895539
    Abstract: The present invention relates to pregnancy hormone combinations and methods of treatment for autoimmune diseases having at least two hormonal components, a pregnancy hormone (such as estriol), and a gestagen (such as levonorgestrel or norethindrone) thereby providing for the continuous, uninterrupted administration of pregnancy hormones for the treatment for autoimmune disorders, such as multiple sclerosis.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: November 25, 2014
    Assignee: The Regents of the University of California
    Inventor: Rhonda R. Voskuhl
  • PREGNANCY HORMONE COMBINATION FOR TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20140127154
    Abstract: The present invention relates to pregnancy hormone combinations and methods of treatment for autoimmune diseases having at least two hormonal components, a pregnancy hormone (such as estriol), and a gestagen (such as levonorgestrel or norethindrone) thereby providing for the continuous, uninterrupted administration of pregnancy hormones for the treatment for autoimmune disorders, such as multiple sclerosis.
    Type: Application
    Filed: January 8, 2014
    Publication date: May 8, 2014
    Applicant: The Regents of the University of California
    Inventor: Rhonda R. VOSKUHL
  • ESTRIOL THERAPY FOR MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES
    Publication number: 20130280213
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including: multiple sclerosis (MS), rheumatoid arthritis (RA), autoimmune thyroiditis and uveitis. Most preferably the invention is used to treat a patient with a therapeutically effective amount of estriol of 8 milligrams once daily via oral administration to treat the symptoms or prevent the onset of multiple sclerosis.
    Type: Application
    Filed: February 11, 2013
    Publication date: October 24, 2013
    Inventor: Rhonda R. VOSKUHL
  • ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASE AND DISORDERS
    Publication number: 20130203722
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, including post-partum auto immune diseases) and more particularly. Most preferably the invention uses estrogens, estranges, estriol or estrogen receptor active agents to prevent or ameliorate clinical symptoms of these Th1-mediated (cell-mediated) autoimmune diseases known to either have an initial onset following the birth of a child or which are exacerbated in patients in the post-partum period.
    Type: Application
    Filed: December 20, 2012
    Publication date: August 8, 2013
    Inventor: Rhonda R. Voskuhl
  • Estriol therapy for multiple sclerosis and other autoimmune diseases
    Patent number: 8372826
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including: multiple sclerosis (MS), rheumatoid arthritis (RA), autoimmune thyroiditis and uveitis. Most preferably the invention is used to treat a patient with a therapeutically effective amount of estriol of 8 milligrams once daily via oral administration to treat the symptoms or prevent the onset of multiple sclerosis.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: February 12, 2013
    Assignee: The Regents of the University of California
    Inventor: Rhonda R. Voskuhl
  • ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES
    Publication number: 20120328566
    Abstract: The present invention relates to treatment of neurological diseases such as multiple sclerosis (MS) and Alzheimer's disease, using an estrogen receptor beta (ER?) ligand in combination with a standard, anti-inflammatory agent.
    Type: Application
    Filed: October 31, 2008
    Publication date: December 27, 2012
    Inventor: Rhonda R Voskuhl
  • Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
    Publication number: 20120282222
    Abstract: This invention relates generally to novel treatments to prevent neurodegeneration in the central nervous system comprising a therapeutic dosage of an estrogen receptor ligand and/or an immunotherapeutic compound, such as beta-interferon, to ameliorate the effects of the neurodegenerative disease and to stimulate repair.
    Type: Application
    Filed: July 8, 2010
    Publication date: November 8, 2012
    Inventors: Rhonda R. Voskuhl, Seema K. Tiwari-Woodruff
  • Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
    Publication number: 20110256096
    Abstract: This invention relates generally to novel treatments to prevent neurodegeneration in the central nervous system comprising a therapeutic dosage of an estrogen receptor ligand and/or an immunotherapeutic compound, such as beta-interferon, to ameliorate the effects of the neurodegenerative disease and to stimulate repair.
    Type: Application
    Filed: July 8, 2010
    Publication date: October 20, 2011
    Inventors: Rhonda R. Voskuhl, Seema K. Tiwari-Woodruff
  • ESTROGEN RECEPTOR LIGAND TREATMENT FOR NEURODEGENERATIVE DISEASES
    Publication number: 20110236350
    Abstract: The present invention relates to treatment of neurological diseases such as multiple sclerosis (MS) and Alzheimer's disease, using an estrogen receptor beta (ER?) ligand in combination with a standard, anti-inflammatory agent.
    Type: Application
    Filed: October 31, 2008
    Publication date: September 29, 2011
    Inventor: Rhonda R Voskuhl
  • Estriol therapy for multiple sclerosis and other autoimmune diseases
    Patent number: 6936599
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including: multiple sclerosis (MS), rheumatoid arthritis (RA), autoimmune thyroiditis and uveitis. Most preferably the invention is used to treat a patient with a therapeutically effective amount of estriol of 8 milligrams once daily via oral administration to treat the symptoms or prevent the onset of multiple sclerosis.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: August 30, 2005
    Assignee: The Regents of the University of California
    Inventor: Rhonda R. Voskuhl
  • Estriol therapy for multiple sclerosis and other autoimmune diseases
    Publication number: 20020183299
    Abstract: The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including: multiple sclerosis (MS), rheumatoid arthritis (RA), autoimmune thyroiditis and uveitis. Most preferably the invention is used to treat a patient with a therapeutically effective amount of estriol of 8 milligrams once daily via oral administration to treat the symptoms or prevent the onset of multiple sclerosis.
    Type: Application
    Filed: April 24, 2002
    Publication date: December 5, 2002
    Applicant: The Regents of the University of California
    Inventor: Rhonda R. Voskuhl